Company intelligence / Profile preview
Vipharm
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
Overview
Vipharm is a prominent Polish pharmaceutical company that specializes in the development, registration, and marketing of high-quality generic and specialty medicinal products. Established in 1998, the company has built a strong presence in Central and Eastern Europe, focusing on critical therapeutic areas such as oncology, hematology, psychiatry, neurology, and cardiology. Vipharm provides a broad portfolio of prescription drugs, particularly targeting the hospital and specialist outpatient markets. The company is recognized for its commitment to making advanced therapies more accessible through affordable generic alternatives. Vipharm operates several international subsidiaries and maintains strategic partnerships to expand its reach across the European Union.
- Therapeutic areas
- PsychiatryCardiovascularNeurologyHematologyOncology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Vipharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vipharm.